Interesting. To me it seems like there isn't really much they can do to impact the PPS until they release the phase 2 trial results early next year. They have to keep paying Salzman for his services by giving him lots of shares every month or quarter, and the recent press release says those shares will be sold in the first 10 days after issue, which means they will be getting poured into the bid. So, I'm guessing the price probably holds itself down for a few more months - at least until Nov/Dec. Just my opinion.
I also think when the phase 3 results come out -- presumably in 2020 -- if those are positive this could have real legs.
News 
Market Data 
Discover 
